Jack Zamora - 11 Nov 2022 Form 3 Insider Report for Vitro Biopharma, Inc.

Role
Director, 10%+ Owner
Signature
/s/ Jack Zamora
Issuer symbol
N/A
Transactions as of
11 Nov 2022
Net transactions value
$0
Form type
3
Filing time
17 Nov 2022, 11:45:07 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding Common Stock 34,177,462 11 Nov 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding Employee Stock Option (Right to Buy) 11 Nov 2022 Common Stock 666,000 $0.2900 Direct F1
holding Employee Stock Option (Right to Buy) 11 Nov 2022 Common Stock 1,000,000 $0.5000 Direct
holding Warrant (Right to Buy) 11 Nov 2022 Common Stock 250,000 $0.5000 Direct
holding Warrant (Right to Buy) 11 Nov 2022 Common Stock 250,000 $1.00 Direct
holding Warrant (Right to Buy) 11 Nov 2022 Common Stock 180,000 $0.5000 Direct
holding Warrant (Right to Buy) 11 Nov 2022 Common Stock 180,000 $1.00 Direct
holding Warrant (Right to Buy) 11 Nov 2022 Common Stock 172,929 $0.5000 Direct
holding Warrant (Right to Buy) 11 Nov 2022 Common Stock 172,929 $1.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option became exercisable as to (i) 333,000 shares on April 9, 2021 and (ii) 333,000 shares on April 9, 2022.